Allogene Therapeutics (ALLO) Appoints Shuyuan Yao as Allogene Overland Biopharm CEO

Go back to Allogene Therapeutics (ALLO) Appoints Shuyuan Yao as Allogene Overland Biopharm CEO
(NASDAQ: ALLO) Delayed: 1.67 -0.04 (2.34%)
Previous Close $1.71    52 Week High
Open $1.73    52 Week Low
Day High $1.74    P/E N/A 
Day Low $1.65    EPS
Volume 5,965,949